menu
    • menu

    Company profile for Elusys Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Elusys Therapeutics is a private company focused on the development of antibody therapeutics for the treatment of infectious disease. For over 10 years, Elusys has been engaged in development of new therapies for the treatment of anthrax exposure following a natural or intentional release of anthrax spores. The company’s management team has extensive experience in late stage biologic drug development and in securing and m...
    Elusys Therapeutics is a private company focused on the development of antibody therapeutics for the treatment of infectious disease. For over 10 years, Elusys has been engaged in development of new therapies for the treatment of anthrax exposure following a natural or intentional release of anthrax spores. The company’s management team has extensive experience in late stage biologic drug development and in securing and managing government contracts supporting drug development. Since 2002, Elusys has received over $240 million in development grants and contracts from the Biomedical Advanced Research and Development Authority (BARDA).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Elusys TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Elusys Therapeutics, Inc. 4 Century Drive, Suite 260 Parsippany, NJ 07054
    Telephone
    Telephone
    1-844-808-0222
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://elusys.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Elusys Finalizes HHS Contract to Deliver ANTHIM, to U.S. Department of HHS
    Elusys Finalizes HHS Contract to Deliver ANTHIM, to U.S. Department of HHS

    31 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/31/2375666/32418/en/Elusys-Therapeutics-Finalizes-HHS-Contract-to-Deliver-ANTHIM-Its-Treatment-for-Inhalation-Anthrax-to-the-U-S-Department-of-Health-and-Human-Services.html

    GLOBENEWSWIRE
    31 Jan 2022
    Share Share
    Elusys Receives Positive CHMP Opinion For Obiltoxaximab SFL
    Elusys Receives Positive CHMP Opinion For Obiltoxaximab SFL

    08 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/elusys-therapeutics-receives-positive-chmp-opinion-for-obiltoxaximab-sfl-for-the-treatment-of-inhalation-anthrax-301148871.html

    PRNEWSWIRE
    08 Oct 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search